Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds — ECLAH

Aesthetics Clinical Trial

Official title:
Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds

Status Completed

Clinical Trial Summary

This study evaluates the injection of a hyaluronic acid dermal filler with lidocaine 0.3% in the treatment of nasolabial folds (NLF). Each patient will receive 1 concentration in a NLF (20 mg/mL) and an other concentration in the other NLF (24 mg/mL).

Clinical Trial Description

Interventional, monocentric, double blind, randomised study Evaluation of safety the 1st month (primary criteria) and until 12 month Evaluation of performance at baseline, month 3, month 6, month 9 and month 12 : WSRS (wrinkle scale), profilometry (image measuring wrinkle depth and area), GAIS : satisfaction scale ;

Study Design

Related Conditions & MeSH terms

Aesthetics

Clinical Trial Details

NCT number	NCT02703740
Study type	Interventional
Source	Laboratoires Genévrier
Contact
Status	Completed
Phase	N/A
Start date	January 11, 2016
Completion date	February 3, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04505319` - Clinical Evaluation of the Safety and Performance of a Filler in Correction of Mid-face Age-related Volume Deficit	N/A
Completed	`NCT02297516` - Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment	Phase 4
Active, not recruiting	`NCT05355454` - Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face	N/A
Recruiting	`NCT05747456` - Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal)	N/A
Withdrawn	`NCT00845078` - Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer	N/A
Completed	`NCT01412190` - Study to Evaluate Restylane Vital Light Using an Injector Device	N/A